Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

Artificial Disc Offers New Option for Back Pain

 

September 19, 2005  |  

Until recently San Diego residents with severe back pain from degenerative disc disease have had few options. But Oceanside resident Joan Steggell decided the traditional treatment, spinal fusion, was not the right choice for her. Instead she opted for an innovative new surgery at UC San Diego's Thornton Hospital.

UC San Diego surgeon, William Taylor, MD, is one of only a few surgeons nationwide trained to replace diseased discs with implanted artificial discs. The artificial disc manufactured by DePuy Spine is made of metal and a movable high-density plastic center that, once implanted, is designed to help align the spine and preserve its ability to move. Spinal discs maintain the position of the spine, allowing patients to bend and twist. Unlike traditional fusion surgery where the surgeon accesses the spine from the backside, Taylor accesses the spine through an incision in the lower abdomen.

“By implanting an artificial disc instead of fusing the spine, the patient has more mobility after surgery,” said Taylor. “The patient doesn’t lose spinal function and is able to return to normal activities much more quickly because there’s no waiting for a fusion to heal.”

The disc was approved by the FDA in October 2004. Before then, Taylor says, when medical interventions such as physical therapy, exercise and pain medication failed, physicians turned to the traditional treatment for degenerative disc disease, spinal fusion surgery --which literally “fuses” two or more adjacent vertebrae together. Spinal fusion is the most common surgical treatment for low back pain; doctors perform over 200,000 procedures annually in the U.S. The procedure immobilizes the vertebrae, preventing further pain, but also limits range of motion. Recovery can take as long as six months, three of them in a back brace, while the vertebrae grow together to form one long bone.

Degenerative disc disease affects 10-12 million people nationwide, 30 percent of them over the age of 30. The disease occurs when the spinal discs deteriorate, losing moisture, height, and tissue integrity. The deterioration causes the vertebrae to rub against one another resulting in severe pain. The natural aging process, low back strain, chronic or repetitive trauma, and the daily stresses of sitting, bending, twisting and bad posture cause the painful condition, which can last indefinitely unless corrected.

The procedure has been available outside the United States since 1987 and has been performed on more than 7500 patients. Although artificial replacements have commonly been implanted in knees and hips, this is the first FDA approval of such a device for spinal discs.

For more information, patients can call 619-543-1965.

# # #

News Media Contact:Jeffree Itrich,  619-543-6163, jitrich@ucsd.edu

Note to broadcast and cable producers: UC San Diego provides an on-campus satellite uplink facility for live or pre-recorded television interviews.  Please
phone, or e-mail, the media contact listed above to arrange an interview.

UC San Diego Health Sciences Communications HealthBeat: /news/




Media Contact

Share This Article


Related News

8/26/2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and l ...
8/24/2016
While even the best wines eventually peak and turn to vinegar, a new study by researchers at University of California San Diego School of Medicine suggests a paradoxical trend in the mental health of ...
8/19/2016
Researchers at the University of California San Diego School of Medicine have found that a form of magnetic resonance imaging (MRI) that non-invasively measures fat density in the liver corresponds wi ...
8/19/2016
Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Strep ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: